Oncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal translocation t(8;21), subvert normal blood cell development by impairing differentiation and driving malignant self-renewal. Here, we use digital footprinting and chromatin immunoprecipitation sequencing (ChIP-seq) to identify the core RUNX1/ETO-responsive transcriptional network of t(8;21) cells. We show that the transcriptional program underlying leukemic propagation is regulated by a dynamic equilibrium between RUNX1/ETO and RUNX1 complexes, which bind to identical DNA sites in a mutually exclusive fashion. Perturbation of this equilibrium in t(8;21) cells by RUNX1/ETO depletion leads to a global redistribution of transcription factor complexes with...
Acute myeloid leukemia (AML) is a heterogeneous disease caused by mutations in transcriptional regul...
The t(8;21) acute myeloid leukemia (AML)-associated oncoprotein AML1-ETO disrupts normal hematopoiet...
SummaryThe t(8;21) acute myeloid leukemia (AML)-associated oncoprotein AML1-ETO disrupts normal hema...
SummaryOncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal tran...
SUMMARY Oncogenic transcription factors such as RUNX1 / ETO, which is generated by the chromosomal t...
SummaryOncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal tran...
Oncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal translocati...
Oncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal translocati...
textabstractAcute myeloid leukemia (AML) is a heterogeneous disease caused by mutations in transcrip...
Acute myeloid leukaemia (AML) is characterized by a block in myeloid differentiation the stage of wh...
Acute myeloid leukemia (AML) is a hematopoietic malignancy caused by recurrent mutations in genes en...
Acute myeloid leukaemia (AML) results from clonal expansion of primitive myeloid cells incapable of ...
Completed under a Cotutelle arrangement between the University of Melbourne and University of Birmi...
The t(8;21) translocation fuses the DNA-binding domain of the hematopoietic master regulator RUNX1 t...
Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the ...
Acute myeloid leukemia (AML) is a heterogeneous disease caused by mutations in transcriptional regul...
The t(8;21) acute myeloid leukemia (AML)-associated oncoprotein AML1-ETO disrupts normal hematopoiet...
SummaryThe t(8;21) acute myeloid leukemia (AML)-associated oncoprotein AML1-ETO disrupts normal hema...
SummaryOncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal tran...
SUMMARY Oncogenic transcription factors such as RUNX1 / ETO, which is generated by the chromosomal t...
SummaryOncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal tran...
Oncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal translocati...
Oncogenic transcription factors such as RUNX1/ETO, which is generated by the chromosomal translocati...
textabstractAcute myeloid leukemia (AML) is a heterogeneous disease caused by mutations in transcrip...
Acute myeloid leukaemia (AML) is characterized by a block in myeloid differentiation the stage of wh...
Acute myeloid leukemia (AML) is a hematopoietic malignancy caused by recurrent mutations in genes en...
Acute myeloid leukaemia (AML) results from clonal expansion of primitive myeloid cells incapable of ...
Completed under a Cotutelle arrangement between the University of Melbourne and University of Birmi...
The t(8;21) translocation fuses the DNA-binding domain of the hematopoietic master regulator RUNX1 t...
Oncogenic fusion protein RUNX1-ETO is the product of the t(8;21) translocation, responsible for the ...
Acute myeloid leukemia (AML) is a heterogeneous disease caused by mutations in transcriptional regul...
The t(8;21) acute myeloid leukemia (AML)-associated oncoprotein AML1-ETO disrupts normal hematopoiet...
SummaryThe t(8;21) acute myeloid leukemia (AML)-associated oncoprotein AML1-ETO disrupts normal hema...